Basal Cell Carcinoma Treatment: Your Options, Explained

Your dermatologist just said the words "basal cell carcinoma," and your mind probably jumped straight to the scariest version of what skin cancer can mean. Take a breath. Basal cell carcinoma is the most common form of skin cancer, and when it is caught early, the large majority of cases are treated successfully in a doctor's office.

This guide walks you through how basal cell carcinoma is treated, what each option involves, and how to know which approach fits your situation, so you can walk into your next appointment feeling informed instead of overwhelmed.

What is basal cell carcinoma, and how serious is it?

Basal cell carcinoma (BCC) is a slow-growing skin cancer that starts in the basal cells of your skin's outer layer, usually on areas that get the most sun, like the face, head, and neck. It is by far the most common skin cancer: an estimated 3.6 million cases are diagnosed in the U.S. each year, and about 1 in 5 Americans will develop some form of skin cancer in their lifetime.

Here is the reassuring part. BCC accounts for roughly 80% of all non-melanoma skin cancers, and it spreads to other parts of the body very rarely, with a metastatic rate of less than 0.1%. Because it grows slowly and almost never spreads, death from BCC is rare. The main goal of treatment is to remove it completely before it grows larger or deeper and damages nearby tissue.

How is basal cell carcinoma diagnosed?

Treatment always starts with a confirmed diagnosis. A dermatologist diagnoses BCC with a skin biopsy, removing a small sample of the suspicious spot and examining it under a microscope. The biopsy confirms the cancer and tells your doctor what subtype you have.

That detail matters, because the best treatment depends on the tumor's type, location, size, and your own preferences. A small, shallow lesion on your back may be handled very differently from a tumor on your nose or near your eye.

Surgical treatments for basal cell carcinoma

For most basal cell carcinomas, surgery is the first-line treatment because it removes the cancer and lets the doctor confirm the margins are clear. There are two main surgical approaches.

Surgical excision means cutting out the tumor along with a margin of healthy-looking skin, then checking the edges under a microscope. This approach is highly effective: surgical excision with histologic margin control has a 5-year recurrence rate of less than 3% on the face.

Mohs micrographic surgery is often called the gold standard, especially for high-risk areas. The surgeon removes the tumor one thin layer at a time and examines each layer under a microscope the same day, continuing only until no cancer cells remain. This spares as much healthy tissue as possible, which is why it is favored for cosmetically and functionally sensitive sites.

• Mohs surgery has the highest cure rate of any BCC treatment: up to 99% for a tumor that has not been treated before, and up to 94% for a tumor that has come back after previous treatment.
• The AAD's Appropriate Use Criteria rate appropriateness across 69 distinct BCC clinical scenarios.
• Mohs is favored for high-risk locations such as the face, ears, lips, and around the eyes, and for tumors that have recurred.

Non-surgical and topical treatment options

Not every basal cell carcinoma needs surgery. For certain superficial or low-risk tumors, your dermatologist may recommend a less invasive option.

Common non-surgical approaches include cryosurgery (freezing the lesion with liquid nitrogen), and curettage and electrodesiccation (scraping away the tumor and then using an electric current to destroy remaining cancer cells). Radiation therapy is an option when surgery is not feasible, for example in patients who cannot undergo an operation. For thin, superficial lesions, prescription topical medications applied to the skin may be appropriate.

Your doctor will weigh these against surgery based on the tumor's characteristics and your overall health. None of these should be started on your own; they require a dermatologist's evaluation and prescription.

Treatment for advanced or metastatic basal cell carcinoma

In the rare cases where BCC grows deeply, spreads locally in ways surgery and radiation cannot fully address, or metastasizes, there are systemic medications designed for advanced disease.

Two hedgehog pathway inhibitors, vismodegib and sonidegib, are approved for locally advanced or metastatic BCC. For patients who progress on or cannot tolerate hedgehog inhibitors, the PD-1 immunotherapy drug cemiplimab is used. These treatments are managed by specialists, and they are reserved for the small minority of cases that cannot be cured with local therapy.

When to see a doctor

Any new growth, a sore that does not heal, a shiny or pearly bump, or a patch that bleeds, crusts, and returns deserves a professional skin check. Because BCC grows slowly, early detection usually means simpler, office-based treatment with excellent outcomes.

If you have already been treated for skin cancer, keep up with your follow-up exams. People who have had one BCC are at higher risk of developing another, and ongoing monitoring helps catch new spots while they are small. A dermatologist, or a clinician-overseen tool like Nolla for tracking changes in your skin over time, can help you stay ahead of it.